Cargando…
Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness
BACKGROUND: Chemotherapy resistance is the major cause of recurrence in patients with colorectal cancer (CRC). A previous study found that Fusobacterium (F.) nucleatum promoted CRC chemoresistance. Additionally, metformin rescued F. nucleatum-induced tumorigenicity of CRC. Here, we aimed to investig...
Autores principales: | Hong, Xia-Lu, Yu, Ta-Chung, Huang, Xiao-Wen, Wang, Ji-Lin, Sun, Tian-Tian, Yan, Ting-Ting, Zhou, Cheng-Bei, Chen, Hui-Min, Su, Wen-Yu, Du, Wan, Xiong, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902563/ https://www.ncbi.nlm.nih.gov/pubmed/36396820 http://dx.doi.org/10.1038/s41416-022-02044-6 |
Ejemplares similares
-
Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis
por: Huang, Xiaowen, et al.
Publicado: (2020) -
Fusobacterium nucleatum and cancer
por: Alon‐Maimon, Tamar, et al.
Publicado: (2022) -
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
por: Liu, Yang, et al.
Publicado: (2020) -
Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment
por: Yu, Ya-Nan, et al.
Publicado: (2015) -
Fusobacterium nucleatum and Colorectal Cancer
por: Li, Rongrong, et al.
Publicado: (2022)